Detalhe da pesquisa
1.
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
Lancet
; 402(10419): 2307-2316, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979595
2.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516125
3.
Atogepant for the Preventive Treatment of Migraine.
N Engl J Med
; 385(8): 695-706, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407343
4.
Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.
Cephalalgia
; 43(1): 3331024221128250, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620892
5.
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
Headache
; 63(1): 79-88, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651532
6.
Ubrogepant for the Treatment of Migraine.
N Engl J Med
; 381(23): 2230-2241, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31800988
7.
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
Cephalalgia
; 42(1): 3-11, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521260
8.
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis.
Headache
; 61(3): 422-429, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749826
9.
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
Headache
; 60(1): 141-152, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913519
10.
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.
Cephalalgia
; 39(14): 1753-1761, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537107
11.
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
JAMA
; 322(19): 1887-1898, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742631
12.
Total plasma homocysteine measurement: Evaluation of the Abbott immunoassay, comparison with the JEOL ion exchange chromatography and investigation of its clinical utility.
Pract Lab Med
; 32: e00295, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992628
13.
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain.
Neurology
; 99(17): e1905-e1915, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977836
14.
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 5(6): e2215499, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675076
15.
Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms.
J Antimicrob Chemother
; 65(10): 2108-15, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713407
16.
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
Lancet Neurol
; 19(9): 727-737, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822633
17.
Myofascial pain and treatment: Editorial.
J Bodyw Mov Ther
; 23(3): 521-531, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563365
18.
A critical overview of the current myofascial pain literature - November 2018.
J Bodyw Mov Ther
; 23(1): 65-73, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30691765
19.
A critical overview of the current myofascial pain literature - February 2019.
J Bodyw Mov Ther
; 23(2): 295-305, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31103111
20.
The relative risk to the femoral nerve as a function of patient positioning: potential implications for trigger point dry needling of the iliacus muscle.
J Man Manip Ther
; 27(3): 162-171, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935326